valproic acid is a promising antiepileptic drug with broad-spectrum activity , and is particularly useful in the treatment of absence and myoclonic seizures , although further clinical experience is required before it can supplant ethosuximide as the preferred drug for the treatment of absence seizures .
C0015043
ethosuximide
C0014553
of absence